Report Detail

Pharma & Healthcare Global Kidney Disease Drugs Market Research Report 2021

  • RnM4296431
  • |
  • 24 March, 2021
  • |
  • Global
  • |
  • 121 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Kidney Disease Drugs Market Overview

  • 1.1 Product Overview and Scope of Kidney Disease Drugs
  • 1.2 Kidney Disease Drugs Segment by Type
    • 1.2.1 Global Kidney Disease Drugs Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Tablets
    • 1.2.3 Capsule
    • 1.2.4 Other
  • 1.3 Kidney Disease Drugs Segment by Application
    • 1.3.1 Kidney Disease Drugs Sales Comparison by Application: (2021-2027)
    • 1.3.2 Chronic Glomerulonephritis
    • 1.3.3 Nephrotic Syndrome
    • 1.3.4 Chronic Renal Failure
    • 1.3.5 Kidney Stones
    • 1.3.6 Renal Cyst (polycystic Kidney)
    • 1.3.7 Diabetic Nephropathy
    • 1.3.8 Hypertensive Nephropathy
    • 1.3.9 Purpura Nephritis
    • 1.3.10 Lupus Nephritis
    • 1.3.11 Pediatric Kidney Disease
  • 1.4 Global Kidney Disease Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Kidney Disease Drugs Revenue 2016-2027
    • 1.4.2 Global Kidney Disease Drugs Sales 2016-2027
    • 1.4.3 Kidney Disease Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Kidney Disease Drugs Market Competition by Manufacturers

  • 2.1 Global Kidney Disease Drugs Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Kidney Disease Drugs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Kidney Disease Drugs Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Kidney Disease Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Kidney Disease Drugs Market Competitive Situation and Trends
    • 2.5.1 Kidney Disease Drugs Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Kidney Disease Drugs Players Market Share by Revenue
    • 2.5.3 Global Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Kidney Disease Drugs Retrospective Market Scenario by Region

  • 3.1 Global Kidney Disease Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Kidney Disease Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Kidney Disease Drugs Market Facts & Figures by Country
    • 3.3.1 North America Kidney Disease Drugs Sales by Country
    • 3.3.2 North America Kidney Disease Drugs Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Kidney Disease Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Kidney Disease Drugs Sales by Country
    • 3.4.2 Europe Kidney Disease Drugs Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Kidney Disease Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Kidney Disease Drugs Sales by Region
    • 3.5.2 Asia Pacific Kidney Disease Drugs Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Kidney Disease Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Kidney Disease Drugs Sales by Country
    • 3.6.2 Latin America Kidney Disease Drugs Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Kidney Disease Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Kidney Disease Drugs Sales by Country
    • 3.7.2 Middle East and Africa Kidney Disease Drugs Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Kidney Disease Drugs Historic Market Analysis by Type

  • 4.1 Global Kidney Disease Drugs Sales Market Share by Type (2016-2021)
  • 4.2 Global Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
  • 4.3 Global Kidney Disease Drugs Price by Type (2016-2021)

5 Global Kidney Disease Drugs Historic Market Analysis by Application

  • 5.1 Global Kidney Disease Drugs Sales Market Share by Application (2016-2021)
  • 5.2 Global Kidney Disease Drugs Revenue Market Share by Application (2016-2021)
  • 5.3 Global Kidney Disease Drugs Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GlaxoSmithKline
    • 6.1.1 GlaxoSmithKline Corporation Information
    • 6.1.2 GlaxoSmithKline Description and Business Overview
    • 6.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GlaxoSmithKline Product Portfolio
    • 6.1.5 GlaxoSmithKline Recent Developments/Updates
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description and Business Overview
    • 6.2.3 Sanofi Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi Product Portfolio
    • 6.2.5 Sanofi Recent Developments/Updates
  • 6.3 Roche
    • 6.3.1 Roche Corporation Information
    • 6.3.2 Roche Description and Business Overview
    • 6.3.3 Roche Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Roche Product Portfolio
    • 6.3.5 Roche Recent Developments/Updates
  • 6.4 Pfizer
    • 6.4.1 Pfizer Corporation Information
    • 6.4.2 Pfizer Description and Business Overview
    • 6.4.3 Pfizer Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Pfizer Product Portfolio
    • 6.4.5 Pfizer Recent Developments/Updates
  • 6.5 AstraZeneca
    • 6.5.1 AstraZeneca Corporation Information
    • 6.5.2 AstraZeneca Description and Business Overview
    • 6.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 AstraZeneca Product Portfolio
    • 6.5.5 AstraZeneca Recent Developments/Updates
  • 6.6 Keryx Biopharmaceuticals
    • 6.6.1 Keryx Biopharmaceuticals Corporation Information
    • 6.6.2 Keryx Biopharmaceuticals Description and Business Overview
    • 6.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Keryx Biopharmaceuticals Product Portfolio
    • 6.6.5 Keryx Biopharmaceuticals Recent Developments/Updates
  • 6.7 Kissei Pharmaceutical
    • 6.6.1 Kissei Pharmaceutical Corporation Information
    • 6.6.2 Kissei Pharmaceutical Description and Business Overview
    • 6.6.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Kissei Pharmaceutical Product Portfolio
    • 6.7.5 Kissei Pharmaceutical Recent Developments/Updates
  • 6.8 AbbVie
    • 6.8.1 AbbVie Corporation Information
    • 6.8.2 AbbVie Description and Business Overview
    • 6.8.3 AbbVie Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 AbbVie Product Portfolio
    • 6.8.5 AbbVie Recent Developments/Updates
  • 6.9 Amgen
    • 6.9.1 Amgen Corporation Information
    • 6.9.2 Amgen Description and Business Overview
    • 6.9.3 Amgen Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Amgen Product Portfolio
    • 6.9.5 Amgen Recent Developments/Updates
  • 6.10 Teva Pharmaceutical Industries
    • 6.10.1 Teva Pharmaceutical Industries Corporation Information
    • 6.10.2 Teva Pharmaceutical Industries Description and Business Overview
    • 6.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Teva Pharmaceutical Industries Product Portfolio
    • 6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
  • 6.11 Tianjin Tongrentang Group
    • 6.11.1 Tianjin Tongrentang Group Corporation Information
    • 6.11.2 Tianjin Tongrentang Group Kidney Disease Drugs Description and Business Overview
    • 6.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Tianjin Tongrentang Group Product Portfolio
    • 6.11.5 Tianjin Tongrentang Group Recent Developments/Updates
  • 6.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
    • 6.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
    • 6.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Description and Business Overview
    • 6.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Product Portfolio
    • 6.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Developments/Updates
  • 6.13 Datong Liqun Pharmaceutical
    • 6.13.1 Datong Liqun Pharmaceutical Corporation Information
    • 6.13.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Description and Business Overview
    • 6.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Datong Liqun Pharmaceutical Product Portfolio
    • 6.13.5 Datong Liqun Pharmaceutical Recent Developments/Updates
  • 6.14 Hebei Ruisen Pharmaceutical
    • 6.14.1 Hebei Ruisen Pharmaceutical Corporation Information
    • 6.14.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Description and Business Overview
    • 6.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Hebei Ruisen Pharmaceutical Product Portfolio
    • 6.14.5 Hebei Ruisen Pharmaceutical Recent Developments/Updates
  • 6.15 Changxing Pharmaceutical
    • 6.15.1 Changxing Pharmaceutical Corporation Information
    • 6.15.2 Changxing Pharmaceutical Kidney Disease Drugs Description and Business Overview
    • 6.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Changxing Pharmaceutical Product Portfolio
    • 6.15.5 Changxing Pharmaceutical Recent Developments/Updates
  • 6.16 zhejiang Shengbokang Pharmaceutical
    • 6.16.1 zhejiang Shengbokang Pharmaceutical Corporation Information
    • 6.16.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Description and Business Overview
    • 6.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 zhejiang Shengbokang Pharmaceutical Product Portfolio
    • 6.16.5 zhejiang Shengbokang Pharmaceutical Recent Developments/Updates

7 Kidney Disease Drugs Manufacturing Cost Analysis

  • 7.1 Kidney Disease Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Kidney Disease Drugs
  • 7.4 Kidney Disease Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Kidney Disease Drugs Distributors List
  • 8.3 Kidney Disease Drugs Customers

9 Kidney Disease Drugs Market Dynamics

  • 9.1 Kidney Disease Drugs Industry Trends
  • 9.2 Kidney Disease Drugs Growth Drivers
  • 9.3 Kidney Disease Drugs Market Challenges
  • 9.4 Kidney Disease Drugs Market Restraints

10 Global Market Forecast

  • 10.1 Kidney Disease Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Kidney Disease Drugs by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Kidney Disease Drugs by Type (2022-2027)
  • 10.2 Kidney Disease Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Kidney Disease Drugs by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Kidney Disease Drugs by Application (2022-2027)
  • 10.3 Kidney Disease Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Kidney Disease Drugs by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Kidney Disease Drugs by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Tablets
    Capsule
    Other

    Segment by Application
    Chronic Glomerulonephritis
    Nephrotic Syndrome
    Chronic Renal Failure
    Kidney Stones
    Renal Cyst (polycystic Kidney)
    Diabetic Nephropathy
    Hypertensive Nephropathy
    Purpura Nephritis
    Lupus Nephritis
    Pediatric Kidney Disease

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    GlaxoSmithKline
    Sanofi
    Roche
    Pfizer
    AstraZeneca
    Keryx Biopharmaceuticals
    Kissei Pharmaceutical
    AbbVie
    Amgen
    Teva Pharmaceutical Industries
    Tianjin Tongrentang Group
    Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
    Datong Liqun Pharmaceutical
    Hebei Ruisen Pharmaceutical
    Changxing Pharmaceutical
    zhejiang Shengbokang Pharmaceutical


    Summary:
    Get latest Market Research Reports on Kidney Disease Drugs. Industry analysis & Market Report on Kidney Disease Drugs is a syndicated market report, published as Global Kidney Disease Drugs Market Research Report 2021. It is complete Research Study and Industry Analysis of Kidney Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,079.16
    3,118.75
    4,158.33
    2,408.80
    3,613.21
    4,817.61
    313,655.30
    470,482.95
    627,310.60
    218,550.96
    327,826.44
    437,101.92
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report